| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/02/2008 | CN101209340A Chinese medicinal composition for treating gastroesophageal reflux disease |
| 07/02/2008 | CN101209339A Wax candle with incense treating function and preparation method thereof |
| 07/02/2008 | CN101209331A Capsule preparations, preparation and quality control method thereof |
| 07/02/2008 | CN101209325A High-efficiency pure Chinese medicinal pill for relaxing bowels |
| 07/02/2008 | CN101209307A Chinese medicinal oral liquid with heat-clearing and detoxication, dampness-eliminating and dysentery-stopping efficacy |
| 07/02/2008 | CN101209306A Chinese medicine granule for treating colibacillosis of avian |
| 07/02/2008 | CN101209305A Chinese medicinal oral liquid for treating colibacillosis of avian |
| 07/02/2008 | CN101209304A Chinese medicinal granule with clearing heat and detoxication, blood-nourishing and dysentery-stopping efficacy |
| 07/02/2008 | CN101209303A Chinese medicinal oral liquid with heat-clearing and detoxication, antimicrobial and anti-inflammation efficacy |
| 07/02/2008 | CN101209296A Chinese medicinal granule with worm-expelling liver-caring, hemostasis and dysentery-stopping efficacy |
| 07/02/2008 | CN101209285A Preparation and application of í«dingguiyouí» soft capsule |
| 07/02/2008 | CN101209278A Folium sennae extract and preparation thereof |
| 07/02/2008 | CN101209273A Preparation of inula japonica total polysaccharide and its application in defaecation and expelling toxin |
| 07/02/2008 | CN101209271A Medicinal composition for preventing helicobacter pylori |
| 07/02/2008 | CN101209269A Application of oligose in soft extract |
| 07/02/2008 | CN101209254A New use of polyhydroxy galloyl-beta-D-glucose derivatives |
| 07/02/2008 | CN101209252A Use of aloperine in preparing medicament for treating chronic hepatitis B |
| 07/02/2008 | CN101209247A Preparation of colon-targeted preparation |
| 07/02/2008 | CN101209103A Health preserving soup |
| 07/02/2008 | CN101209098A Grape jujube with spleen-and-stomach-invigorating function |
| 07/02/2008 | CN101209096A Edible porridge and preparation method thereof |
| 07/02/2008 | CN101209066A Various grains í«saqimaí» |
| 07/02/2008 | CN100398557C Polypeptide for inhibition of angiogenesis and method for preparing same and use thereof |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398519C Tetracyclic benzamide derivatives and methods of use thereof |
| 07/02/2008 | CN100398149C Application of human sDR5 protein as medicine to treat virus hepatitis B |
| 07/02/2008 | CN100398144C Liver-nourishing electruary |
| 07/02/2008 | CN100398132C Medicine used for kidney supplementing and its preparation method |
| 07/02/2008 | CN100398131C Infant spleen-tonifying fast dispersion solid preparation and its preparation method |
| 07/02/2008 | CN100398124C Medicine for treating chronic hepatitis and its preparing method |
| 07/02/2008 | CN100398118C Externally used non-toxic bacteriostatic bactericidal traditional medicine preparation and its preparing technics |
| 07/02/2008 | CN100398116C Medicine for treating stomatocase and laryngopharyngitis |
| 07/02/2008 | CN100398115C Medicine for treating alcohol liver damage and its preparing method |
| 07/02/2008 | CN100398114C Composition of stachyose and bee product |
| 07/02/2008 | CN100398110C Preparation containing ultra-low-doses of estrogen, patch and reagent box |
| 07/02/2008 | CN100398108C Nasal cavity nebula containing scopolamine hydrobromide |
| 07/02/2008 | CN100398099C Stomachache easing dripping pills with celandine as raw materials and its preparation process |
| 07/01/2008 | US7393925 structural modification alters the biological persistence, preferably the biological half-life |
| 07/01/2008 | US7393875 Reducing islet amyloid polypeptide (IAPP) associated deposit; type II diabetes |
| 07/01/2008 | US7393860 for the treatment of peptic ulcer disorders; (7R,8R,9R)-2,3-Dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydro-imidazo-[1,2-h][1,7] naphthyridine or a pharmaceutically acceptable salt |
| 07/01/2008 | US7393859 Amide substituted imidazoquinolines |
| 07/01/2008 | US7393845 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 07/01/2008 | US7393842 Pyrazole analogs acting on cannabinoid receptors |
| 07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393551 Denatured carob flour (DCF) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 07/01/2008 | US7393545 Lipstatin derivative—soluble fiber tablets |
| 06/26/2008 | WO2008076949A2 Quinazoline derivatives and methods of treatment |
| 06/26/2008 | WO2008076703A1 Methods and compositions for treating gastrointestinal disorders |
| 06/26/2008 | WO2008076042A1 Azetidinpiperazine derivatives that are neurokinin (nk) receptor antagonists and their use. |
| 06/26/2008 | WO2008076041A1 Azetidinazabicyclo [3.2.1] octan derivatives that are neurokinin (nk) receptor antagonists and their use. |
| 06/26/2008 | WO2008075949A1 Modulation of human microsomal triglyceride transfer protein (mtp or mttp) gene expression by food-grade/ingested dietary microorganisms |
| 06/26/2008 | WO2008075888A1 A composition comprising the extract of combined herbs for preventing and treating liver disease |
| 06/26/2008 | WO2008075621A1 Antacid |
| 06/26/2008 | WO2008075462A1 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion |
| 06/26/2008 | WO2008074676A1 Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors |
| 06/26/2008 | WO2008074473A2 Uses and methods for preventing and/or treating caries caused by mutants streptococci |
| 06/26/2008 | WO2008074080A1 Composition and method for treatment of ibs |
| 06/26/2008 | US20080153927 Dicyclomine antispasmodic agent, Mephobarbital barbiturate, Chlordiazepoxide tranquilizer, Citalopram selective serotonin reuptake inhibitor, Alosetron 5-HT3 receptor antagonist; achalasia, Barrett's syndrome, biliary dyskinesia, Crohn's disease, chronic intestinal pseudo-obstruction, colonic inertia |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153881 For therapy of achalasia, Barrett's syndrome, biliary dyskinesia, Crohn's disease, chronic intestinal pseudo-obstruction, colonic inertia, constipation, cyclic vomiting syndrome, diarrhea, diffuse esophageal spasm, dumping syndrome, dyspepsia, dysphagia, encopresis, fecal incontinence |
| 06/26/2008 | US20080153880 For therapy of achalasia, Barrett's syndrome, biliary dyskinesia, Crohn's disease, chronic intestinal pseudo-obstruction, colonic inertia, constipation, cyclic vomiting syndrome, diarrhea, diffuse esophageal spasm, dumping syndrome, dyspepsia, dysphagia, encopresis, fecal incontinence |
| 06/26/2008 | US20080153873 Dihydrobenzofuranyl derivatives and methods of their use |
| 06/26/2008 | US20080153864 Spiroazabicyclic Heterocyclic Compounds |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153833 Substituted pteridines for the treatment of inflammatory diseases |
| 06/26/2008 | US20080153832 Synergistic mixture with antispasmodic agent, a barbiturate, a tranquilizer, a selective serotonin reuptake inhibitor, or a 5-HT3 receptor antagonist; gastrointestinal disorders, Crohn's disease, irritable bowel syndrome, diarrhea, vomiting, dyskinesias, incontinence, pain, inflammatory bowel disease |
| 06/26/2008 | US20080153829 Pan-alpha-2 receptor agonist and 5ht4 serotonin receptor compositions for treating gastrointestinal motility disorders |
| 06/26/2008 | US20080153825 Alpha-2b receptor agonist and 5ht4 serotonin receptor compositions for treating gastrointestinal motility disorders |
| 06/26/2008 | US20080153742 Fas peptide mimetics and uses thereof |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152637 Methods of treating and diagnosing parkinsons disease and related dysautonomic disorders |
| 06/26/2008 | US20080152628 Augmentation and repair of spincter defects with cells including mesenchymal cells |
| 06/26/2008 | US20080152627 Muscle Derived Cells For The Treatment Of Gastro-Esophageal Pathologies And Methods Of Making And Using The Same |
| 06/26/2008 | DE102006062264A1 Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen Use of xanthohumol for preventing and / or combating liver disease |
| 06/26/2008 | CA2690273A1 Use of prostaglandin ep4 agonist for treating gastrointestinal disorders |
| 06/26/2008 | CA2672719A1 Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors |
| 06/26/2008 | CA2672515A1 Oral health composition comprising alchemilla vulgaris |
| 06/26/2008 | CA2672270A1 Treatments of therapy resistant diseases and drug combinations for treating the same |
| 06/25/2008 | EP1935892A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |
| 06/25/2008 | EP1935882A1 Bicyclic compounds |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1934215A1 Isotopically substituted imidazopyridine derivatives for the treatment of gastrointestinal disorders |
| 06/25/2008 | EP1934209A1 5- (phenylisoxazolylethoxy) -triazol- 3 -yl substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders |
| 06/25/2008 | EP1934201A1 Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
| 06/25/2008 | EP1933833A1 Therapy for the treatment of disease |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1377164B1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 06/25/2008 | EP1354592B1 Medicines for relieving intestinal disorders |
| 06/25/2008 | EP1351683B1 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser |
| 06/25/2008 | EP1328271B1 Treatment of neurological and neuropsychological disorders |
| 06/25/2008 | EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 06/25/2008 | EP1041991B1 Non antibacterial tetracyclins for the treatment of multiple sclerosis |
| 06/25/2008 | CN101208345A (S)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
| 06/25/2008 | CN101208344A (R)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
| 06/25/2008 | CN101208330A Method of preparing esomeprazole and salts thereof |
| 06/25/2008 | CN101208078A Oral medicament based on a proton pump inhibitors |
| 06/25/2008 | CN101205517A Body-tonifying heath life-beneficial wine |
| 06/25/2008 | CN101205237A Extraction of high-purity lecithin from animal livers |
| 06/25/2008 | CN101205234A Curcumin-zinc compound as well as solid dispersion preparation and uses thereof |